Natalia Rost, MD, MPH, FAAN, FAHA, chief of the stroke division at Massachusetts General Hospital and chair of the American Academy of Neurology (AAN) Science Committee, previews the annual meeting and provides a glimpse into what the conference has to offer and its legacy of 75 years.
Natalia Rost, MD, MPH, FAAN, FAHA, chief of the stroke division at Massachusetts General Hospital and chair of the American Academy of Neurology (AAN) Science Committee, talks about the offerings of the 2023 annual meeting taking place April 22-27 in Boston, Massachusetts.
Transcript
What can attendees look forward to at the 75th American Academy of Neurology (AAN) Annual Meeting?
It’s a platinum jubilee for us as an organization. As you know, the Academy is the largest professional organization of neurologists and neuroscience and neurology professionals in the world with more than 40,000 members. We're really excited to bring this celebration of neurology into Boston, and again offer to our members an in-person as well as virtual format. There's going to be something for everybody.
There's more than 3000 original submissions, translated into over 26 presentations: 400 of them in a scientific platform format, and more than 2000 poster presentations. So whatever neurological subspecialty you're coming from, whether it's stroke, movement disorders, epilepsy, many more, you're going to be able to find a platform presentation that you'd be interested in. Or you're going to be able to browse the “poster neighborhoods” as we call them, to find some of the exciting science. In addition to that, we have 7 plenary sessions that are spread out over 6 days. We have more than a number of research hub presentations, which are less of a structured, and more of a bring-science-closer-to-the-members format. We have invited science sessions, we have neuroscience in the clinic sessions, so as you can see, there's a lot going to be going on. That's in addition to education, advocacy, practice, and all sorts of other fun sessions that we're going to be offering to the members, including our epic opening party that's going to take place in the Boston Museum of Science.
AXS25: Health Policy, Drug Costs, and AI Highlights From the Conference
May 6th 2025Asembia’s AXS25 Summit covered a variety of relevant topics in the pharmaceutical industry, from the effects of the new administration to how artificial intelligence (AI) is reshaping the patience experience.
Read More
Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR
May 5th 2025KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, as highlighted at the 2025 meeting of the American Association for Cancer Research (AACR).
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More